on LinkedIn][Scott+Scott on X]Get RSS Feed## Scott+Scott Attorneys at Law LLP Alerts Investors of Its Investigation Into Hub Group, Inc. (NASDAQ: HUBG)NEW YORK--([BUSINESS WIRE])--Scott+Scott Attorneys at Law LLP ("Scott+Scott†), a shareholder and consumer rights litigation firm, is investigating whether Hub Group, Inc. ("Hub Group†or the "Company†) (NASDAQ: HUBG) or certain of its officers and directors issued misleading and false statements and/or failed to disclose information material to investors i ...

Core Viewpoint - Scott+Scott Attorneys at Law LLP has filed a class action lawsuit against Picard Medical Inc. and several associated defendants, alleging violations of the Securities Exchange Act due to misleading statements and a fraudulent stock promotion scheme that led to significant losses for investors [1][3]. Group 1: Lawsuit Details - The lawsuit is filed in the U.S. District Court for the Northern District of California under the case name Louie v. Picard Medical, Inc. et al., with a lead plaintiff deadline set for April 3, 2026 [1][5]. - The class action targets individuals and entities that purchased Picard Medical Securities (PMI) between September 2, 2025, and October 31, 2025, who suffered damages as a result [1][4]. Group 2: Allegations Against Defendants - The complaint alleges that the defendants made materially false and misleading statements and failed to disclose adverse facts about Picard Medical's business and operations [3]. - It is claimed that the defendants orchestrated a "pump-and-dump" scheme, where the stock price was artificially inflated through a social media promotion involving impersonators posing as legitimate financial advisors [2][3]. Group 3: Company Overview - Picard Medical is involved in the design, manufacturing, and sale of medical devices, with its flagship product being the artificial heart "SynCardia TAH" [2]. - The company is headquartered in Tucson, Arizona, and operates in the United States, Europe, and China [2].